Special Offer. Now 25% off the original price of $3500.
In the nascent, but rapidly growing field of stem cell therapies, products are a long way from being commercialized. However, the market potential for stem cell therapies products is very large. This report aims to identify those technologies and opportunities in the United States with the greatest future opportunities, the opportunities to develop enabling technologies in the field, and the organizations and laboratories performing current research. In addition, a section is included that covers the legislative, political and social issues surrounding stem cell technology and research. These issues are impacting the development of the technology.

Objectives

This report is a convenient and comprehensive report on stem cells and the technologies being development. Objectives of the report include the following:

• To describe research activities and potential
• To outline problems involved in developing these technologies and the fairly rigorous regulatory challenges that companies will be facing when licensing these new therapies.
• To provide the kind of current information and analysis the reader will need to make strategic business or investment decisions in the area of stem cell technology.
• To provide in-depth information on most companies, organizations, and research facilities involved in the field.

Audience

This report is designed to be used primarily by executives, investors, venture capitalists, and business development managers and analysts involved in the pharmaceutical or biotechnology areas that may have an interest in stem cell technology. Companies and organizations seeking to identify partners with complementary technologies may also find this report valuable.

Stem cell research and the accompanying enabling technologies have virtually exploded since embryonic stem cells were first isolated in 1998. Many of the enabling and complementary technologies impacting stem cells are only now catching up to the rate of research. As such, there is a section on companies supplying the research, including those with cell lines, cell and tissue culture media, and reagents. The report includes detailed profiles and information on:

• 82 companies involved in the development of stem cell therapeutics, worldwide,
• 57 academic organizations involved in stem cell research in the U.S.,
• 19 laboratories outside the U.S. with advanced research in the field,
• 20 detailed profiles on key companies in the industry,
• 32 suppliers to the Stem Cell Industry, of media, sera, and reagents specifically intended for stem cell research,
• 10 organizations on the NIH list as suppliers having embryonic stem cell lines.
• 149 key researchers at academic organizations worldwide, and
• 11 key researchers at commercial organizations.

Because of the early stages of product development, near-term estimates on products currently in development would be pure speculation. The vast majority of products to be discussed have yet to be developed, and we expect any projections made here would be shown to be inaccurate within 5 years.

Related Reports:

Drug Delivery Markets: Implantable / Injectable and Needle-Free Delivery Systems
Sep 1, 2009 - KLI2422083 - $2,995.00

The World Market for Biosimilars and the Potential for US Follow-on Biologics
Aug 1, 2009 - KLI2402283 - $3,700.00

The World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition
May 1, 2009 - KLI2218043 - $3,995.00

Cell Culture: The World Market for Media, Sera and Reagents, 2nd Edition
May 1, 2009 - KLI2091313 - $3,995.00

Stem Cell Therapeutics Markets
Feb 1, 2009 - KLI2021959 - $2,500.00

Pharmaceutical Outsourcing Post-Launch : Contract Manufacturing, Biomanufacturing and Sales, 3rd Edition
Jan 1, 2009 - KLI1646605 - $3,500.00

Biophotonics: A Strategic Assessment of Photonics Technologies for Biomedical Applications, 2nd Edition
Dec 1, 2008 - KLI1928788 - $3,995.00

Key Genetic Technologies Market Research Bundle (SNPs, Gene Expression Profiling, DNA Sequencing and Analytical Chips)
Nov 1, 2008 - KLI1689637 - $7,995.00

Biogenerics: The World Market for Biosimilars
Apr 1, 2008 - KLI1399521 - $3,500.00

Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
Mar 1, 2008 - KLI1597988 - $3,995.00